Gemina Labs
About:
Gemina Labs is a transformative biochemistry firm that develops next-generation testing platforms for detecting pathogens.
Website: https://www.geminalabs.com/
Top Investors: Syniad Innovations
Description:
Gemina Labs has created and patented a transformative bio-chemistry platform that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals. The tests are quick, inexpensive, and accurate, and they can be self-administered, providing consumers with immediate results. They are developers of novel surface binders, which are critical to the speed, affordability, and accuracy of the pathogen detection platform.
9M CAD
$1M to $10M
Vancouver, British Columbia, Canada
2017-01-01
investor(AT)geminalabs.com
1-10
2024-11-13
Public
© 2025 bioDAO.ai